|
Sep 8
|
3 No-Brainer Dividend Stocks to Buy in September
|
|
Aug 30
|
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
|
|
Aug 30
|
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
|
|
Aug 30
|
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
|
|
Aug 30
|
2 Incredibly Cheap Healthcare Stocks to Buy Now
|
|
Aug 29
|
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
|
Aug 29
|
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
|
|
Aug 29
|
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
|
|
Aug 28
|
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
|
|
Aug 28
|
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
|
|
Aug 27
|
AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases
|
|
Aug 27
|
SkinMedica® Revolutionizes Skin Hydration with the Introduction of HA5® Hydra Collagen Replenish + Restore Hydrator
|
|
Aug 27
|
Should Invesco Large Cap Value ETF (PWV) Be on Your Investing Radar?
|
|
Aug 26
|
Donald Trump Owns These 21 Dividend Kings. Should You?
|
|
Aug 25
|
3 Unstoppable Dividend Stocks to Buy Right Now
|
|
Aug 25
|
Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 78% Return On Equity?
|
|
Jul 29
|
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 28
|
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
|
|
Jul 27
|
AbbVie Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|